Who We Are

PPMI is a collaboration of researchers, funders, and study participants working toward the goal of identifying progression biomarkers to improve PD therapeutics.

Study Partners

PPMI is sponsored and partially funded by The Michael J. Fox Foundation for Parkinson's Research (MJFF) with support from the Aligning Science Across Parkinson's (ASAP) initiative. Other partners include a consortium of industry players, non-profit organizations and private individuals.

Partners are contributing to PPMI through financial and in-kind donations and are playing a lead role in providing feedback on study parameters through the Partner Scientific Advisory Board (PSAB). Through close interaction with the study, the PSAB is positioned to inform the selection and review of potential progression markers that could be used in clinical testing.

Interested in collaborating?

MJFF is eager to partner with organizations to make PPMI a success. If your organization is interested in exploring opportunities for collaboration, contact us.

Click here to download a text document of the current list of study partners.